VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce that its common… Read More
BURLINGTON, NC – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to FORTUNE® magazine’s 2025 list of the World’s Most Admired Companies,™ a… Read More
MyTrials.ai receives milestone investment from Providence Health Care Ventures PHC Ventures is investing $100K in MyTrials.ai, a company founded by Dr. Zachary Laksman, an in-house entrepreneur and clinician with Providence Health… Read More
The latest Times Higher Education subject rankings reflect UBC’s global leadership in health research, education, partnership and impact. UBC is among the best universities in the world for Medical and… Read More
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer’s disease progression does not stop after plaque clearance; ongoing treatment with LEQEMBI… Read More
